Single-Cell Analysis – News and Features

Themes discussed at February’s AGBT 2017 – held across the peninsula in Hollywood Beach while its traditional home is being renovated – focused on the latest developments in NGS technology and the growing interest in single cell analyses.

Researchers at the University of Geneva have devised a genomic technique for identifying new imprinted genes.

Researchers have demonstrated a method of barcoding cells multiple times and then sequencing them. The method greatly expands the number of single cells that can be mapped.

Mapping the transcriptome of neurons with development will enable better understanding of brain function. Being able to target specific classes of interneurons will enable researchers to tease out their function and predict how these brain areas will respond to therapies.

Mapping gene expression in single cells may allow researchers to study how cancerous tumors begin.

The Rubicon acquisition will allow the Takara Bio Group to augment and expand its worldwide commercial offerings in next generation sequencing (NGS) sample preparation and expand into new markets.

The collaboration aims to create a microfluidic single-cell sequence analysis technology which can be used to help develop immunotherapeutics.

Novel CRISPR-based single-cell genetics platform, Perturb-seq, enables large-scale analysis of complex genetic interactions.

Discovery brings with it possible implications for brain regeneration.

Researchers have used single-cell analysis technology to provide new insight into the Salmonella infection process.